Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

Sebastian Zschaeck; Bibiana Blümke; Peter Wust; David Kaul; Marcus Bahra; Hanno Riess; Fritz Klein; Marianne Sinn; Uwe Pelzer; Volker Budach; Pirus Ghadjar

doi:10.1371/journal.pone.0186341

Loading metrics

Open Access

Peer-reviewed

Research Article

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

Sebastian Zschaeck ,

Roles Formal analysis, Investigation, Validation, Visualization, Writing – original draft

* E-mail: Sebastian.Zschaeck@charite.de

Affiliation Charité Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany

http://orcid.org/0000-0003-3109-0662

⨯
Bibiana Blümke,

Roles Data curation, Formal analysis, Investigation

Affiliation Charité Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany
⨯
Peter Wust,

Roles Conceptualization, Data curation, Supervision, Writing – review & editing

Affiliation Charité Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany
⨯
David Kaul,

Roles Resources, Supervision

Affiliation Charité Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany
⨯
Marcus Bahra,

Roles Conceptualization, Data curation

Affiliation Charité Universitätsmedizin Berlin, Department of General, Visceral, and Transplantation Surgery, Berlin, Germany
⨯
Hanno Riess,

Roles Conceptualization, Investigation

Affiliation Charité Universitätsmedizin Berlin, Department of Hematology/Oncology/Tumorimmunology, Berlin, Germany
⨯
Fritz Klein,

Roles Investigation

Affiliation Charité Universitätsmedizin Berlin, Department of General, Visceral, and Transplantation Surgery, Berlin, Germany
⨯
Marianne Sinn,

Roles Data curation, Investigation

Affiliation Charité Universitätsmedizin Berlin, Department of Hematology/Oncology/Tumorimmunology, Berlin, Germany
⨯
Uwe Pelzer,

Roles Conceptualization, Investigation, Supervision

Affiliation Charité Universitätsmedizin Berlin, Department of Hematology/Oncology/Tumorimmunology, Berlin, Germany
⨯
Volker Budach,

Roles Investigation, Resources, Supervision

Affiliation Charité Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany
⨯
Pirus Ghadjar

Roles Conceptualization, Formal analysis, Investigation, Supervision, Writing – review & editing

Affiliation Charité Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany
⨯

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

Sebastian Zschaeck,
Bibiana Blümke,
Peter Wust,
David Kaul,
Marcus Bahra,
Hanno Riess,
Fritz Klein,
Marianne Sinn,
Uwe Pelzer,
Volker Budach

Published: October 12, 2017
https://doi.org/10.1371/journal.pone.0186341

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Pancreatic cancer
Is the Subject Area "Pancreatic cancer" applicable to this article?

Thanks for your feedback.
Stomach
Is the Subject Area "Stomach" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.